Implementing steroid profiling by liquid chromatography-tandem mass spectrometry improves newborn screening for congenital adrenal hyperplasia in New Zealand.
Mark R de HoraNatasha L HeatherTejal PatelLauren G BresnahanDianne WebsterPaul L HofmanPublished in: Clinical endocrinology (2021)
A second-tier LCMSMS newborn screening test for CAH offers significant improvements to screening specificity without any other changes to screening protocols.